210 related articles for article (PubMed ID: 36358737)
41. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
42. CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy.
Michot JM; Mouraud S; Adam J; Lazarovici J; Bigenwald C; Rigaud C; Tselikas L; Dartigues P; Danu A; Bigorgne A; Minard V; Ghez D; Marabelle A; Zitvogel L; Ribrag V
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771650
[No Abstract] [Full Text] [Related]
43. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
44. BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders.
Rodig SJ; Shahsafaei A; Li B; Mackay CR; Dorfman DM
Hum Pathol; 2005 Oct; 36(10):1113-9. PubMed ID: 16226112
[TBL] [Abstract][Full Text] [Related]
45. Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody.
Agostinelli C; Paterson JC; Gupta R; Righi S; Sandri F; Piccaluga PP; Bacci F; Sabattini E; Pileri SA; Marafioti T
Histopathology; 2012 Jul; 61(1):33-46. PubMed ID: 22394247
[TBL] [Abstract][Full Text] [Related]
46. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of a low density DNA microarray for small B-cell non-Hodgkin lymphoma differential diagnosis.
Gillet JP; Molina TJ; Jamart J; Gaulard P; Leroy K; Briere J; Theate I; Thieblemont C; Bosly A; Herin M; Hamels J; Remacle J
Leuk Lymphoma; 2009 Mar; 50(3):410-8. PubMed ID: 19294557
[TBL] [Abstract][Full Text] [Related]
48. Checkpoint CD47 expression in classical Hodgkin lymphoma.
Gholiha AR; Hollander P; Löf L; Glimelius I; Hedstrom G; Molin D; Hjalgrim H; Smedby KE; Hashemi J; Amini RM; Enblad G
Br J Haematol; 2022 Jun; 197(5):580-589. PubMed ID: 35301709
[TBL] [Abstract][Full Text] [Related]
49. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
50. The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target.
Iseulys R; Anne GB; Corinne B; Gonzague DBP; Marie K; Jean-Yves B; Aurélie D
J Bone Oncol; 2020 Feb; 20():100271. PubMed ID: 31956474
[TBL] [Abstract][Full Text] [Related]
51. Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome.
Augé H; Notarantonio AB; Morizot R; Quinquenel A; Fornecker LM; Hergalant S; Feugier P; Broséus J
Front Immunol; 2020; 11():594841. PubMed ID: 33381116
[TBL] [Abstract][Full Text] [Related]
52. PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas.
Xie W; Medeiros LJ; Li S; Yin CC; Khoury JD; Xu J
Curr Hematol Malig Rep; 2020 Aug; 15(4):372-381. PubMed ID: 32394185
[TBL] [Abstract][Full Text] [Related]
53. Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
Ling HY; Yang Z; Wang PJ; Sun Y; Ju SG; Li J; Fu JX
Chem Biol Interact; 2022 Jan; 352():109779. PubMed ID: 34922904
[TBL] [Abstract][Full Text] [Related]
54. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma.
Pizzi M; Trentin L; Visentin A; Saraggi D; Martini V; Guzzardo V; Righi S; Frezzato F; Piazza F; Sabattini E; Semenzato G; Rugge M
Hum Pathol; 2019 Mar; 85():251-259. PubMed ID: 30458196
[TBL] [Abstract][Full Text] [Related]
55. CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma.
Martín-Moreno AM; Roncador G; Maestre L; Mata E; Jiménez S; Martínez-Torrecuadrada JL; Reyes-García AI; Rubio C; Tomás JF; Estévez M; Pulford K; Piris MA; García JF
PLoS One; 2015; 10(6):e0125203. PubMed ID: 26066800
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of tissue-infiltrating immune cells in tumor microenvironment of follicular lymphoma: A meta-analysis.
Xie M; Jiang Q; Zhao S; Zhao J; Ye X; Qian W
Int Immunopharmacol; 2020 Aug; 85():106684. PubMed ID: 32540726
[TBL] [Abstract][Full Text] [Related]
57. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
58. Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer.
Shinohara H; Kobayashi M; Hayashi K; Nogawa D; Asakawa A; Ohata Y; Kubota K; Takahashi H; Yamada M; Tokunaga M; Kinugasa Y; Oda G; Nakagawa T; Onishi I; Kinowaki Y; Kurata M; Ohashi K; Kitagawa M; Yamamoto K
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362023
[TBL] [Abstract][Full Text] [Related]
59. Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma.
Harada K; Dong X; Estrella JS; Correa AM; Xu Y; Hofstetter WL; Sudo K; Onodera H; Suzuki K; Suzuki A; Johnson RL; Wang Z; Song S; Ajani JA
Gastric Cancer; 2018 Jan; 21(1):31-40. PubMed ID: 28801853
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathological analysis of immunohistochemical expression of immune checkpoint molecules in follicular lymphoma.
Yanagida E; Miyoshi H; Takeuchi M; Shimono J; Nakashima K; Yamada K; Kawamoto K; Moritsubo M; Shimasaki Y; Inoue K; Imamoto T; Furuta T; Kohno K; Ohshima K
Hematol Oncol; 2022 Oct; 40(4):530-540. PubMed ID: 35122292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
